<qa>  What is the amount of bone loss that is seen in patients who are not treated with a1. That treatment with the bisphosphonate, zoledronate, at the time of liver transplantation and at 1 month post-transplantation will prevent the early transplant-related bone loss measured by bone densitometry and biochemical bone markers at 3 months seen in patients who are not treated with a bisphosphonate 